Flying Brand Share Discussion Threads

[dudleym1975] 04/8/2017 12:50

Ramped share by the same twitter group

[andrbea] 04/8/2017 09:33

up 5%

lse board says:

Tue 01:26

EarlyInvestor

All about the mrkt cap here not SP

Its all about the tiny market cap here.

Even at 50p its trading at similar valuations to peers.

A long way to go on up from here

Really excited about the weeks and months for FBDU

Ceo has massive skin in the game as well

Expect FBDU to be the biggest multi bagger of the year

Watch this space folks

[clocktower] 27/7/2017 11:52

On the march once again for no apparent reason - how long before we see a round of funding?

[dudleym1975] 25/7/2017 16:17

The twitter rampers the usual ones

[clocktower] 25/7/2017 11:52

Who is driving this today?

[dudleym1975] 25/7/2017 11:38

Heavily ramped share beware

[dudleym1975] 19/7/2017 08:22

This share stinks the way it has been set up to coerce people into buying its dog shares.

[clocktower] 11/7/2017 12:20

Is today's news just a forerunner to a fund raising to finance the process?

Beware.

[h0me] 11/7/2017 09:20

Getting this into the market will be a lengthy process. Cannot see any income here for years.

[hedgehog 100] 07/7/2017 20:28

yasX4 Jul '17 - 00:41 - 189 of 191 1 0
"Your points are duly noted.
I have laid out just some of the significant concerns that exist ... "


YasX,

A major concern of mine, and one which seems to have been missed by the prospectus, is the heavy reliance on non-recurring revenues. This means that a continual stream of new customers will be needed just to maintain sales at the same level ... which may be difficult once the 'low-hanging fruit' is exhausted.

That's one reason why medical equipment companies tend to be lowly-rated compared to biotechs.

Furthermore, the relatively small amount of money raised leaves little room for error, but experience tells me that the vast majority of start-ups do not meet their projections - maybe one in a hundred or so does.

The company is targeting a penetration rate of 3 - 4% of the kidney stone market in the UK for StoneChecker in the first 12 months from launch, a level which it seems to regard as low.
However, capturing even a few % of a market is pretty high, and can be challenging to achieve.

Trevor Brown has shown that's he's prepared to back FBDU at 1.1p and 1.5p, but at the moment investors are being asked to pay about two or three times those prices, which looks too high given the risks.

Speculative stocks like this can often boom for a while on newsflow before crashing back, so there may be money to be made here as a trading punt, but at the current price of 3.25p there are more attractive risk-reward ratios elsewhere.


P.S. There is also a potential overhand from Peterhouse:

"E.1 Total net proceeds / expenses

The Net Proceeds of the Placing are approximately £416,562. The total expenses incurred (or to be incurred) by the Company in connection with Admission, the Acquisition and the Placing are approximately £184,688, however Peterhouse will be taking their commission of £41,250 and fees of £10,000 (which have been included in the total expenses figure) through the issue of Ordinary Shares at Admission."

[hedgehog 100] 05/7/2017 15:12

03/07/2017 07:00 UKREG Flying Brands Limited Conversion of Convertible Loan Notes into Equity
"… Following this conversion, Flying Brands has GBP213,800 of Convertible Loan Notes outstanding and GBP100,000 of convertible loan notes issued pursuant to a loan note instrument dated 18 November 2015 outstanding.
… On Admission, the Company will have 64,786,721 Ordinary Shares in issue. …"



Monday's RNS highlights the large number of convertible loan notes outstanding:
213,800 convertible @ 1.1p, = 19,436,363 new shares if converted
100,000 convertible @ 1.5p, = 6,666,667 new shares if converted
= 26,103,030 new shares if all converted

+ 64,786,721 shares currently in issue, would = 90,889,751 shares, i.e. a 40.3% increase

At the current FBDU share price of 3.125p, that would equate to a market capitalisation of £2.84M.


Conversion of these convertible loan notes doesn't bring in any more cash, as the money was subscribed in 2015, although it does reduce/remove the convertible loan debt.

[clocktower] 04/7/2017 07:47

Good stuff yasX but I think you are far to generous in respect of your valuation, and I mean generous to excess. If it was feasible to short this while all the ramping/boiler room tactics are taking place I guess you would be up in line.

[clocktower] 03/7/2017 11:35

More warrants as well, filling the pockets of one, allowing for sizable profits, I gave warnings a long time ago about this practice, with this business. BEWARE!!!

[yasx] 03/7/2017 11:13

*If this has the ability to 'revolutionise' a billion dollar market in the near term, why did Feedback, who essentially developed it, let it go to Trevor Brown for 45k only months ago?

*If it so clear to you that this will capture billions or tens of millions in sales very soon, why did the founder sell it to Feedback last year for one grand?

*Why did Brown sell it to FBDU last month for 240k rather than keeping this gargantuan business soon to be yielding billions for himself? Philanthropy? "the aggregate purchase price for the Target, on the basis that 8,000,000 Consideration Shares would still be issued to the Sellers, is now £240,000 as the Company’s share price at suspension was £0.03"

*As for all these sales,it is not even ready to be sold, nor is it even certain that it will clear hurdles to be able to be sold. From the prospectus last month: " In the event that the results from the fourth study are unsatisfactory the StoneChecker product may require further trials in order to prove whether or not it is capable of commercial sales" FBDU's words, not mine.

*This is what the Co. expects in terms of next years sales: "it will be possible to sell 30 units of the one-off server version of the software in the UK during the first twelve months of launching the StoneChecker product at a target price of £15,000 per licence" ie £450k. That is sales, not profit. So, strip out all the cash and investment to get to that stage, hardly a monumental offering is it.

Obviously, the 450k raised is all but accounted for (the prospectus details in itemised form how the funds will be used for purposes of ongoing trials and obtaining regulatory approvals. Where will they get additional funds from to develop and market this next year? Don't ask me, ask the Co, it clearly states: "Once the Net Proceeds have been exhausted, the Company will be dependent on the income generated by the Target and its business to meet the Company’s expenses and operating cash requirements"

Think those 450k in anticipated sales not likely to go very far next year...

[clocktower] 30/6/2017 16:23

End in tears imo but well done to those that have profited.

[fillipe] 27/6/2017 18:49

Bio - what did the twitterati say? Bull or bear?

f

[bionictwat] 27/6/2017 18:22

Don't listen to rampers like smugden on twitter

[andrbea] 27/6/2017 12:23

gone blue...

[clocktower] 27/6/2017 08:29

Stone Checker Software , since re-admission excitement it seems like it is as predicted sinking, maybe better to think of Flying Brands once again as Sinking Stones when it comes to investment.

[pyglet] 16/6/2017 16:29

Out, thank god.

[clocktower] 16/6/2017 15:33

I`ll be surprised if it does not end in tears for some. Almost 60 million shares and how long before they need cash for something or other?

[andrbea] 16/6/2017 15:25

has shown how illiquid it is
was up 42% at one stage, 11% now

[clocktower] 16/6/2017 12:09

Remember another Channel Island Company called ML Labs that was in the kidney research business and where that went.

Still it has had a good start but how long before it sinks below the issue price?